Needham Maintains Buy on Boston Scientific, Lowers Price Target to $77

Benzinga Newsdesk www.benzinga.com Negative 58.1%

Neg 58.1% Neu 0% Pos 0%

Needham analyst Mike Matson maintains Boston Scientific (NYSE:BSX) with a Buy and lowers the price target from $97 to $77.